Literature DB >> 16865191

A novel mutation of the VMD2 gene in a Chinese family with best vitelliform macular dystrophy.

Yang Li1, Guanglu Wang, Bing Dong, Xiuying Sun, Matthew J Turner, Shin Kamaya, Kang Zhang.   

Abstract

INTRODUCTION: In this paper, we report a novel VMD2 gene mutation in a Chinese family with Best vitelliform macular dystrophy.
MATERIALS AND METHODS: Ophthalmologic examination and optical coherence tomography (OCT) were performed in 2 members of this family. Mutational screening was performed by single-strand conformation polymorphism (SSCP) and direct sequencing of PCR-amplified DNA fragments, corresponding to the 11 exons of the gene.
RESULTS: Sequence analysis identified a previously unreported C to G change, predicting a Phe-113-Leu substitution. Both the proband and his sister harboured this novel mutation. Each had bilateral vitelliform lesions.
CONCLUSIONS: A novel mutation in the VMD2 gene (C427G) was found in Chinese patients with Best vitelliform macular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865191

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  3 in total

1.  Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy.

Authors:  Elliott H Sohn; Peter J Francis; Jacque L Duncan; Richard G Weleber; David A Saperstein; Donald F Farrell; Edwin M Stone
Journal:  Arch Ophthalmol       Date:  2009-07

2.  Choroidal neovascularization secondary to Best's vitelliform macular dystrophy in two siblings of a Malay family.

Authors:  Koh Alisa-Victoria; Tan Jin-Poi; Ismail Shatriah; Embong Zunaina; Nor Fariza Ngah
Journal:  Clin Ophthalmol       Date:  2014-03-12

3.  Screening for BEST1 gene mutations in Chinese patients with bestrophinopathy.

Authors:  Rong Tian; Guoxing Yang; Jing Wang; Youxin Chen
Journal:  Mol Vis       Date:  2014-11-11       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.